Viewing nowKojanyu Tablet 50mg (Losartan Potassium)
Losartan Potassium 50mg
Tablet · Prescription medication
Sears Pharmaceutical Co., Ltd.

MFDS item code 201902235 · Approved 2019.04.11 · Insurance code 689000580
Treatment of hypertension and nephropathy in patients with type 2 diabetes mellitus accompanied by hypertension
This medication lowers blood pressure in hypertensive patients, reducing the burden on the heart and blood vessels. It is particularly helpful in the prevention and treatment of kidney disease in patients with both hypertension and type 2 diabetes. This helps to prevent deterioration of kidney function and supports overall blood pressure management. Therefore, it is used effectively in the management of kidney disease in patients with hypertension and diabetes.
This medicine may be taken with or without food, but it is recommended that it be taken at the same time each day. 1. Hypertension 1) Adults The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect occurs 3 ∼ 6 weeks after starting treatment. If the response is insufficient, the same dose may be divided into 2 doses per day, or the dose may be increased to 100 mg once daily if necessary. 3) If blood pressure is not controlled with this medicine alone, it may be administered in combination with another antihypertensive agent (e.g., a low dose of a diuretic). An additive effect has been observed when administered in combination with hydrochlorothiazide. 2. Nephropathy in patients with type 2 diabetes and hypertension The usual adult dose of this medicine is 50 mg once daily. Depending on blood pressure, the dose may be increased to 100 mg once daily. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered in combination with insulin and commonly used antihyperglycemic agents (e.g., sulfonylureas, glitazones, and glucosidase inhibitors). 3. Special patient groups 1) Elderly patients No adjustment of the initial dose is necessary in elderly patients aged 75 years or younger. For elderly patients over 75 years, an initial dose of 25 mg of this medicine once daily is recommended. 2) Patients with renal impairment (1) Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. (2) Creatinine clearance < 20 mL/min and patients on dialysis: An initial dose of 25 mg of this medicine once daily is recommended. 3) Patients with reduced effective intravascular volume For patients who may have reduced effective intravascular volume (e.g., patients receiving diuretics), an initial dose of 25 mg of this medicine once daily is recommended (see the Precautions for Use section). 4) Patients with hepatic impairment Consider administering a lower dose to patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
Children and adolescents 6 years and older, weighing 20 kg or more and less than 50 kg, who can swallow tablets: The recommended dose is 25 mg of this medicine once daily, which may be increased to a maximum of 50mg once daily depending on the patient's blood pressure response. Children and adolescents 6 years and older, weighing 50 kg or more: The usual recommended dose is 50 mg of this medicine once daily, which may be increased to a maximum of 100 mg once daily depending on the patient's blood pressure response. Pediatric patients under 6 years: Not recommended. Pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡: Not recommended. Pediatric patients with hepatic impairment: Not recommended.
This medication can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters. Therefore, if pregnancy is confirmed, it should be discontinued immediately. Taking this medication during pregnancy may lead to decreased fetal kidney function, lung development problems, and skeletal deformities, and there is also a risk of hypotension and renal failure in the newborn. Patients with allergies to this medication, those who are pregnant, have severely impaired liver function, or have certain hereditary diseases should not take it. Elderly patients, those with weakened kidney function, or patients whose blood pressure is excessively low should take this medication with caution and regularly monitor blood pressure and kidney function. While this medication is generally safe, side effects such as dizziness, muscle cramps, back pain, cold symptoms, and rhinitis may occur. In rare instances, serious side effects such as angioedema, liver function abnormalities, muscle pain, hyperkalemia, and hypoglycemia can occur, so caution is needed. This medication may interact with other antihypertensives, certain diuretics, and potassium supplements, so consultation with a doctor is essential. Particularly, combining it with drugs that can increase potassium levels may increase the risk of hyperkalemia, so caution is advised. It is important to regularly check blood pressure, kidney function, and electrolyte levels while on this medication to ensure there are no abnormalities. Women who are pregnant or planning to become pregnant should consult healthcare providers, and this medication should not be taken during pregnancy. Nursing mothers should also avoid taking this medication, and if necessary, breastfeeding should be discontinued. This medication is not to be used in children, especially those under 6 years of age or in children with severely impaired kidney function. Symptoms of a drastic drop in blood pressure may occur, so when starting the medication or increasing the dosage, it should be done gradually with close monitoring of the condition. In case of overdose, symptoms such as hypotension and rapid heartbeat may appear, and immediate medical attention should be sought if necessary. This medication should be kept out of reach of children and not transferred to other containers for safety.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to prevent air and moisture ingress and should be kept at a temperature between 1 and 30 degrees Celsius. Storing it this way helps maintain the efficacy and prevents degradation of the medication.
White oval film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowLosartan Potassium 50mg
Tablet · Prescription medication
Sears Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
DaeWon Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Korea United Pharm, Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
HK Inno.N Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
IYON Pharmaceuticals Co., Ltd.
Losartan Potassium
Prescription medication
JW ShinYak Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Kukje Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.